Clinical Trial Update: Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial of a personalized neoantigen cancer vaccine for adults with solid tumors; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Personalized Neoantigen Cancer Vaccine

Snippet

Sponsor: Seqker Biosciences, Inc. | Conditions: Cancer, Solid Tumor, Adult | Phase 1, Phase 2 | Status: COMPLETED